Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 20 (HNRNPA1P20) is a pseudogene related to the HNRNPA1 gene, which encodes an RNA-binding protein involved in RNA processing and gene regulation[1]. As a pseudogene, HNRNPA1P20 does not encode a functional protein and is generally considered non-functional in terms of coding capacity. Pseudogenes typically arise from duplication or retrotransposition events and may share sequence similarity with functional genes but lack essential coding potential due to mutations or incomplete sequences. There is no evidence that HNRNPA1P20 acts as a receptor, enzyme, transporter, or therapeutic target, nor are there drugs, biomarkers, or safety concerns specifically associated with it[1]. If you are seeking information on the functional protein, refer to "Heterogeneous nuclear ribonucleoprotein A1" (HNRNPA1), not this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 20 (HNRNPA1P20).